Udayavni Special

ICMR developing portal for info on COVID-19 vaccine


PTI, Aug 23, 2020, 9:21 AM IST

New Delhi: The apex health research body, ICMR, is in the process of developing a vaccine portal that will provide information related to the COVID-19 vaccine development in India and abroad, with the majority of the updates in several regional languages in addition to English.

“The aim of creating the portal is to provide all information and updates relating to the COVID-19 vaccine development at one platform as all the information in this regard is scattered as of now,” Samiran Panda, Head of Epidemiology and Communicable Diseases at ICMR, told PTI.

“The idea behind making the updates available in regional languages is to make sure every citizen is able to access the information. The portal is likely to be functional by next week,” Panda said.

The portal would be made operational in phases. In the first phase, the portal will provide all information related to the COVID-19 vaccine in India and abroad.

“Over a period of time, information about all other vaccines used to prevent various other ailments will be put on the portal,” he said.

In India, three COVID-19 vaccine candidates, including two indigenous ones, are in different phases of clinical trials.

“The phase-1 human clinical trials of the two COVID-19 vaccine candidates developed indigenously by Bharat Biotech in collaboration with ICMR and Zydus Cadila Ltd have been completed and the trials have moved to phase 2,” Indian Council of Medical Research Director General Balram Bhargava had recently said at a press briefing.

The Serum Institute of India, which has partnered with AstraZeneca for manufacturing the COVID-19 vaccine candidate developed by the University of Oxford, has been permitted for conducting Phase 2 and 3 human clinical trials of the candidate in India. It is likely to start the trials next week.

According to Union Health Ministry data updated at 8 am on Saturday, the country saw a record single-day spike of 69,874 infections, taking the country’s COVID-19 caseload to 29,75,701, while the death toll due to the disease climbed to 55,794 with 945 fatalities being reported in a 24-hour span.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

No weekend Curfew in DK; lockdown-like restrictions remain

EC to set up ‘core committee’ to identify shortcomings during recently-held assembly polls

Task Force set up to oversee preparation for probable third wave of COVID-19: BSY

COVID-19: Karnataka reports 35,297 new cases, 344 deaths

Beltangady: Six arrested for illegal sand mining at Netravati

Gap between two doses of Covishield extended from 6-8 weeks to 12-16 weeks: Govt

NHRC issues notices to Centre, UP & Bihar over bodies found floating in Ganga



Related Articles More

Gap between two doses of Covishield extended from 6-8 weeks to 12-16 weeks: Govt

Super spreader: 67-year-old Kumbh Mela returnee infects 33 with Covid-19 in Bengaluru

Sudhakar seeks IISc’s support in tackling COVID-19

US-approved vaccines effective against B.1.617 variant of Covid-19: Official

Karnataka: Vaccination drive for 18-44 age group ‘temporarily suspended’

MUST WATCH

Covid Impact on the Sandalwood Industry

ರಾಬರ್ಟ್ ಚಿತ್ರ Tonic ಆಯ್ತು

Groom Plays The Band At His Own Wedding

Outrage at Dictatorial Attitude: Mass Resignation from Doctors in Unnao

BMTC launches Oxygen Bus Service

Latest Additions

No weekend Curfew in DK; lockdown-like restrictions remain

EC to set up ‘core committee’ to identify shortcomings during recently-held assembly polls

Task Force set up to oversee preparation for probable third wave of COVID-19: BSY

COVID-19: Karnataka reports 35,297 new cases, 344 deaths

Beltangady: Six arrested for illegal sand mining at Netravati

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.